GridAI Technologies (GRDX) Tax Rate (2024 - 2026)
GridAI Technologies' (GRDX) quarterly Tax Rate came in at 0.42% in Q2 2026, up 100.34% quarter-over-quarter from 124.05% in Q2 2024.
Powered by 
Analysis
GridAI Technologies (GRDX) Tax Rate (2024 - 2026) Analysis & Trends
GridAI Technologies (GRDX) has reported Tax Rate for 2 consecutive years, with 0.42% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Tax Rate changed N/A year-over-year to 0.42%; the trailing twelve-month figure through Jun 2026 stood at 22.35% (down 24739.0% YoY), and the FY2025 full-year result was 6.01%, changed N/A from the prior year.
- Tax Rate advanced to 0.42% in Q2 2026 per GRDX's latest filing, from 124.05% in the prior quarter.
- Across five years, Tax Rate topped out at 163.3% in Q1 2024 and bottomed at 124.05% in Q2 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.12 Bn | 192.13 Bn | 7.24 Bn | 14.20% |
| 2 | Gilead Sciences | 180.16 Bn | 176.98 Bn | 6.22 Bn | -2.36% |
| 3 | Vertex Pharmaceuticals | 131.52 Bn | 123.67 Bn | 2.84 Bn | 20.98% |
| 4 | Regeneron Pharmaceuticals | 81.95 Bn | 73.96 Bn | 3.93 Bn | 15.11% |
| 5 | Argenx Se | 60.36 Bn | 55.18 Bn | 1.37 Bn | -10.89% |
| 6 | Moderna | 53.81 Bn | 48.67 Bn | 52.00 Mn | -1.96% |
| 7 | Alnylam Pharmaceuticals | 33.01 Bn | 29.70 Bn | 992.69 Mn | 7.49% |
| 8 | Biogen | 31.96 Bn | 30.67 Bn | 1.96 Bn | 26.36% |
| 9 | Roivant Sciences | 29.25 Bn | 29.25 Bn | 1.16 Mn | 1.34% |
| 10 | GridAI Technologies | 19.39 Mn | 19.39 Mn | -36,514.00 | 0.42% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.42% |
| Jun 30, 2024 | -124.05% |
| Mar 31, 2024 | 163.30% |